COVID-19 Burden in Hospitals Affects Risk for In-Hospital Adverse Events
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 7, 2024 -- Greater hospital COVID-19 burden is associated with an increased risk for in-hospital adverse events (AEs) among patients with and without COVID-19 in the United States, according to a study published online Nov. 4 in JAMA Network Open.
Mark L. Metersky, M.D., from the University of Connecticut School of Medicine in Farmington, and colleagues examined whether hospital COVID-19 burden was associated with the rate of in-hospital AEs in a cohort study including 40,737 Medicare hospital admissions (4,114 patients with COVID-19 and 36,623 without).
The researchers found there were 59.1, 77.0, and 97.4 AEs per 1,000 admissions during weeks with the lowest, intermediate, and highest COVID-19 burden, respectively. There were 55.7, 74.0, and 79.3 AEs per 1,000 admissions during weeks with the lowest, intermediate, and highest COVID-19 burden among patients without COVID-19. Patients with COVID-19 had a similar pattern. For all patients, the relative risk for AEs among those admitted during weeks with high versus low COVID-19 burden was 1.23 after risk adjustment, with similar results among those with and without COVID-19.
"These results illustrate the need for greater resilience, including systems of care that promote patient safety and planning for surge capacity in hospitals to prevent declines in patient safety and effectiveness of care during increases in demand, such as from pandemics, natural disasters, or other causes," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and...
AAP Updates Guidance on Evaluation, Treatment of Patent Ductus Arteriosus in Preemies
THURSDAY, May 15, 2025 -- In a clinical report published in the May issue of Pediatrics, the American Academy of Pediatrics presents updated guidance on the evaluation and...
Some Triple Negative Breast Cancers Might Be Avoided by Longer Breastfeeding
THURSDAY, May 15, 2025 -- Shorter breastfeeding duration and younger age at first birth are known risk factors for triple negative breast cancer (TNBC) and vary by race, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.